Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
转移性三阴性乳腺癌患者 sacituzumab govitecan 与化疗对比的 III 期 ASCENT 研究中生物标志物分析
期刊:Annals of Oncology
影响因子:56.7
doi:10.1016/j.annonc.2021.06.002
A Bardia, S M Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, A Zelnak, P Aftimos, F Dalenc, S Sardesai, E Hamilton, P Sharma, S Recalde, E C Gil, T Traina, J O'Shaughnessy, J Cortes, M Tsai, L Vahdat, V Diéras, L A Carey, H S Rugo, D M Goldenberg, Q Hong, M Olivo, L M Itri, S A Hurvitz